`Alzheimer`s drug to be developed within five years`
Washington: Scientists have said that a drug that could provide a breakthrough for Alzheimer's disease will be available within the next five years.
Recruitment of people aged 55 - 90 to take part in the final-stage study in the US is taking place. The study will examine if the drug solanezumab slows the cognitive and functional decline of people who suffer from mild Alzheimer's.
In the new trial expected to end by December 2016, people are going to be given solanezumab as a monthly 400mg injection for 18 months.
Dr Eric Karran, director of research at Alzheimer's Research UK, said that the results would suggest that monthly injections should be given early to ward off the disease, News.com.au reported.
Dr Karran said that the drug showed "reasonable" effect in people suffering from mild Alzheimer's and results would come within five years.
Download the all new Zee News app for Android and iOS to stay up to date with latest headlines and news stories in Politics, Entertainment, Sports, Technology, Business and much more from India and around the world.
More from India
More from World
More from Sports
More from Entertaiment
- Dr Subhash Chandra Show: How to expand your existing business
- Entire Indian force can't defend Kashmir from terrorists, says Farooq Abdullah
- Prashant Bhushan questions Arvind Kejriwal on Lokpal through press conference
- UP: DM B Chandrakala participates in anti-riots drill in Bulandshahr
- PM Modi addresses the nation during Maan Ki baat
- Women fit only to deliver children, gender equality un-islamic: Kerala Muslim leader
- Sheena Bora murder: Why did Indrani send servant to Kolkata to get illegal drugs?
- Russian MP dies while ‘having sex’ inside car - Read
- Ban on Salman Rushdie's 'The Satanic Verses' by Rajiv Gandhi govt was a mistake: P Chidambaram
- Russia strikes down Goa, India from its safe travel destinations list